Language
Grade: Pharmaceutical Grade
Factory Location: Xiamen, Fujian
Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East
Sample Provided: yes
Payment Terms: L/L
|
Product Information |
|
Product name |
Azilsartan |
|
Molecular Formula |
C25H20N4O5 |
|
Molecular Weight |
456.45 |
|
CAS No. |
147403-03-0 |
|
Quality Standard |
99% up,JP / GMP/ PMDA/DMF, medical grade |
|
Appearance |
White powder |
|
COA of Azilsartan |
|
Analysis Items |
Specification |
Result |
|
Appearance |
White to almost white powder |
Almost white powder |
|
Identification |
Meet reference standard |
Conform |
|
Loss on drying |
NMT 0.5% |
0.1% below |
|
Specified impurity (RRT2.1) |
NMT 0.1% |
0.01% below |
|
Specified impurities(RRT2.4) |
NMT0.1% |
0.01% |
|
Any other individual impurity |
NMT 0.1.% |
0.04% |
|
Total impurity |
NMT 0.5% |
0.08% |
|
Ethanol |
NMT 5000ppm |
37ppm |
|
Acetone |
NMT 5000ppm |
10ppm below |
|
Assay |
NLT 99% calculated on the dried basis |
99.6% |
|
Usage |
Azilsartan is an angiotensin II receptor inhibitor that lowers blood pressure by blocking the activity of the angiotensin II receptor, compared with angiotensin-converting enzyme inhibitor (ACEI) antihypertensive drugs. It has the advantage of smooth blood pressure, does not cause dry cough.